Teva Pharmaceutical Industries Ltd. (TEVA)

8.25
0.20 2.37
NYSE : Health Technology
Prev Close 8.45
Open 8.61
Day Low/High 8.19 / 8.61
52 Wk Low/High 7.96 / 25.96
Volume 16.41M
Avg Volume 15.92M
Exchange NYSE
Shares Outstanding 1.09B
Market Cap 9.13B
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Wild Week Ahead

The intermediate-term sentiment indicators don’t show too much giddiness -- yet -- but look at all the market has on its plate this week.

Teva Announces Launch Of A Generic Version Of Tracleer® (bosentan) Tablets In The United States

Teva Announces Launch Of A Generic Version Of Tracleer® (bosentan) Tablets In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Tracleer ®1 (bosentan) tablets, 62.

U.S. Steel, Insperity, NovoCure: 'Mad Money' Lightning Round

U.S. Steel, Insperity, NovoCure: 'Mad Money' Lightning Round

Jim Cramer weighs in on U.S. Steel, Insperity, NovoCure, Aqua America, Universal Display, Teva Pharmaceuticals, Marathon Petroleum and more.

Can Stocks Be Fun?: Cramer's 'Mad Money' Recap (Monday 6/17/19)

Can Stocks Be Fun?: Cramer's 'Mad Money' Recap (Monday 6/17/19)

Jim Cramer says investing can be fun and rewarding -- if you really understand what you own. But keep your eye on the Fed this week.

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly's plan to eliminate pain could have farther reaching positive effects than just migraines.

Teva Shares Rebound on Oppenheimer Upgrade

Teva Shares Rebound on Oppenheimer Upgrade

Shares of drugmaker Teva surge after receiving an upgrade from Oppenheimer, albeit with a reduced 12-month price target.

The Oracle of Omaha Is Off His Game

The Oracle of Omaha Is Off His Game

Be careful backing Buffett right now, his biggest holdings show increasing profit pressure.

Jim Cramer: This Is Now an Emotional Market

Jim Cramer: This Is Now an Emotional Market

When traders are flailing and investors are drowning, examples work best to illustrate what happens before a bottom is reached.

Buffett's Berkshire Hathaway Closes Below $300,000

Buffett's Berkshire Hathaway Closes Below $300,000

Shares of Warren Buffett's investment vehicle, Berkshire Hathaway, ended the day below $300,000 for the first time since late March.

Teva To Present New Fremanezumab FOCUS Clinical Study Data For The First Time At The 13th European Headache Federation Congress

Teva To Present New Fremanezumab FOCUS Clinical Study Data For The First Time At The 13th European Headache Federation Congress

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that data from the Phase IIIb FOCUS study, which evaluated the efficacy and safety of fremanezumab for the preventive treatment of migraine in adult patients who previously...

Teva Plummets on Downgrade Following $85M Opioid Settlement

Teva Plummets on Downgrade Following $85M Opioid Settlement

Shares of Teva plummet Tuesday after UBS downgrades the stock to neutral from buy in light of opioid-related litigation.

Teva Announces Launch Of A Generic Version Of Ranexa® (ranolazine) Extended-Release Tablets In The United States

Teva Announces Launch Of A Generic Version Of Ranexa® (ranolazine) Extended-Release Tablets In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa ®1 (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.

Fiat Chrysler, Renault, Alibaba, Teva and Huawei - 5 Things You Must Know

Fiat Chrysler, Renault, Alibaba, Teva and Huawei - 5 Things You Must Know

U.S. stock futures are lower as caution still prevails amid concerns over the fate of trade talks between Washington and Beijing; the French government says it jobs protected needs in order to support the proposed merger of Fiat Chrysler and Renault; Alibaba is considering raising $20 billion through a second listing in Hong Kong, a report says.

Teva Settles With Oklahoma Over Opioid Allegations

Teva Settles With Oklahoma Over Opioid Allegations

Israeli drugmaker says its payment of $85 million to the state is not an admission of wrongdoing; Johnson & Johnson subsidiary Janssen Pharmaceuticals meanwhile also defends company and says its open to a resolution.

Company Statement: Teva Reaches Agreement With State Of Oklahoma To Resolve State's Claims Against The Company

Company Statement: Teva Reaches Agreement With State Of Oklahoma To Resolve State's Claims Against The Company

Teva Pharmaceuticals USA and related affiliates of Teva Pharmaceutical Industries Ltd.

Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7%

Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7%

Gainers trail losers in Warren Buffett's Berkshire portfolio.

TEVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teva Pharmaceutical Industries Limited To Contact The Firm

TEVA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Teva Pharmaceutical Industries Limited To Contact The Firm

NEW YORK, May 13, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE:TEVA).

Dow Ends Sharply Lower; Trade War Escalation Slams Stocks

Dow Ends Sharply Lower; Trade War Escalation Slams Stocks

China's retaliatory tariffs spark biggest selloff on Wall Street since January.

How Low Can Teva Pharmaceutical Stock Go? Don't Fight the Tape

How Low Can Teva Pharmaceutical Stock Go? Don't Fight the Tape

Do not try to pick a bottom on this stock.

Teva Falls as Drugmakers Alleged to Have Artificially Inflated Prices

Teva Falls as Drugmakers Alleged to Have Artificially Inflated Prices

Attorneys general from 44 states allege the nation's largest generic drugmakers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs.

Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan

Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan

Endo Pharmaceutical is downgraded to underweight from neutral at JPMorgan.

Stock Selloff, Trade War, Teva, Take-Two and Oil Prices - 5 Things You Must Know

Stock Selloff, Trade War, Teva, Take-Two and Oil Prices - 5 Things You Must Know

U.S. stock futures fall sharply after China vows to stand its ground in the escalating trade war with the United States; oil prices surge after Saudi Arabia alleges two of its tankers were victims of a 'sabotage attack,' Teva and other drugmakers are alleged to have conspired to artificially inflate and manipulate prices for generic drugs.

Teva Announces The Launch Of A Generic Version Of Delzicol® (mesalamine) Delayed-Release Capsules In The United States

Teva Announces The Launch Of A Generic Version Of Delzicol® (mesalamine) Delayed-Release Capsules In The United States

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Delzicol ®1 (mesalamine) delayed-release capsules, 400 mg, in the U.

Teva Announces Launch Of A Generic Version Of Tarceva® (erlotinib) Tablets In The United States

Teva Announces Launch Of A Generic Version Of Tarceva® (erlotinib) Tablets In The United States

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a generic version of Tarceva ®1 (erlotinib) tablets, 100 and 150 mg, in the U.

Teva To Present New Long-Term Data On Efficacy And Safety Of Fremanezumab At 2019 American Academy Of Neurology Annual Meeting

Teva To Present New Long-Term Data On Efficacy And Safety Of Fremanezumab At 2019 American Academy Of Neurology Annual Meeting

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced results from new long-term analyses of the efficacy and safety of fremanezumab, being presented at the 71 st Annual Meeting of the American Academy of Neurology (AAN) in...

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

Teva Pharmaceuticals CEO: Stock on Track for 2020 Turnaround

But is a Teva turnaround still coming after the stock's 70% loss in the past five years?

Teva Reports First Quarter 2019 Financial Results

Teva Reports First Quarter 2019 Financial Results

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended March 31, 2019.

Teva Announces Launch Of A Generic Version Of Letairis® (ambrisentan) Tablets In The United States

Teva Announces Launch Of A Generic Version Of Letairis® (ambrisentan) Tablets In The United States

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Letairis ®1 (ambrisentan) Tablets, 5 mg and 10 mg, in the U.

Teva To Present New Central Nervous System Portfolio Data At 71st Annual Meeting Of The American Academy Of Neurology

Teva To Present New Central Nervous System Portfolio Data At 71st Annual Meeting Of The American Academy Of Neurology

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the Company will present data at the 71 st Annual Meeting of the American Academy of Neurology (AAN) in Philadelphia from May 4-10, 2019.

New Highs Washing Away

Lack of new highs and abundance of new lows make task of finding stocks to go long on harder.

TheStreet Quant Rating: D (Sell)